News

Sharp has invested more than €20 million to boost injectable packaging, assembly, and cold-chain storage at its Belgium and Netherlands sites, enhancing CDMO services for pharmaceutical clients.

China's Livzon Pharmaceutical Group, via subsidiary Lian SGP, offers to acquire nearly 78% of Vietnamese drugmaker Imexpharm for US$262.6 million, signaling aggressive expansion in Southeast Asian manufacturing and contract services.

The European Parliament is set to adopt its negotiating position on Tuesday for enhanced EU supply of critical medicines like antibiotics and vaccines, focusing on manufacturing upgrades and stockpiling coordination.

Sichuan Kelun-Biotech presented its latest R&D advancements, commercialized ADC products, and global expansion plans at the 44th J.P. Morgan Healthcare Conference on January 15, 2026.

Industry leaders are collaborating at Pharmapack Europe 2026 to drive education and adoption of Near Field Communication (NFC) technologies in pharmaceutical packaging for enhanced supply chain security and compliance.

U.S. pharmaceutical giant AbbVie has entered a blockbuster $5.6 billion licensing agreement with Chinese biotech RemeGen for global rights to its experimental cancer drug RC148, excluding Greater China.

South Korea's Celltrion announced plans for 16 IND submissions by 2028 and U.S. manufacturing expansion to bolster biopharma supply chain resilience.

Shanghai-based Abbisko Therapeutics announces U.S. FDA acceptance of NDA for pimicotinib, its CSF-1R inhibitor for tenosynovial giant cell tumor, building on China NMPA approval and Merck KGaA global license.

Spanish pharmaceutical company ESTEVE announces acquisition of TerSera's Infusion Specialty Therapies unit, gaining US market expansion with Prialt and Quzyttir while consolidating European operations.

China-based Lynk Pharmaceuticals has announced positive Phase III topline results for its selective JAK1 inhibitor zemprocitinib in rheumatoid arthritis, strengthening its late-stage immunology pipeline and commercialization partnership with Simcere in Greater China.